Clever Leaves (CLVR) Stock Price, News & Analysis

Company Overview

Clever Leaves Holdings Inc. (NASDAQ: CLVR) is a vertically integrated medical cannabis company engaged in the cultivation, processing, manufacturing and distribution of pharmaceutical-grade cannabinoid products. Since its inception, the company has built a global platform designed to meet the rigorous quality and compliance standards required by international regulators. Clever Leaves focuses on producing dried flower, extracts and finished dose formulations that serve the evolving needs of patients and healthcare providers.

The company operates large-scale cultivation facilities in Colombia and Portugal, both of which comply with Good Manufacturing Practices (GMP). These facilities leverage Colombia’s near-equatorial climate to reduce energy consumption during cultivation, while Portugal’s high-tech greenhouse complexes ensure year-round production and stringent environmental controls. Clever Leaves uses a combination of proprietary cultivation techniques, solvent-less extraction methods and precision formulation capabilities to deliver consistent cannabinoid profiles and novel delivery forms.

Clever Leaves sells its products into a growing portfolio of markets across North America, Europe and Latin America. Its customer base includes licensed pharmaceutical distributors, research institutions and select wellness brands seeking pharmaceutical-grade inputs. The company has established supply agreements in Germany, the United Kingdom and Canada, and is positioning itself to serve emerging medical markets in the United States and other jurisdictions where regulatory frameworks are evolving.

Under the leadership of CEO James C. Miller III and an executive team with deep experience in pharmaceuticals, agriculture and regulatory affairs, Clever Leaves has prioritized strategic partnerships and product innovation. The company continues to expand its research and development efforts, exploring novel botanical extractions and advanced delivery systems. With a focus on quality, compliance and scalable production, Clever Leaves aims to meet the long-term needs of the global medical cannabis industry.

Key Stats

• Today's Range: $0.0002 to $0.0002
• 50-Day Range: N/A
• 52-Week Range: $0.00 to $2.65
• Volume: 2,684 shs
• Average Volume: 1,724 shs
• Market Capitalization: $351.00
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

CLVR Stock Analysis - Frequently Asked Questions

How have CLVR shares performed this year?

Clever Leaves' stock was trading at $0.0002 at the start of the year. Since then, CLVR stock has increased by 0.0% and is now trading at $0.0002.

When did Clever Leaves' stock split?

Clever Leaves's stock reverse split on Friday, August 25th 2023.The 1-30 reverse split was announced on Thursday, August 24th 2023. The number of shares owned by shareholders was adjusted after the market closes on Thursday, August 24th 2023. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split.

How do I buy shares of Clever Leaves?

Shares of CLVR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Clever Leaves own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Clever Leaves investors own include NVIDIA (NVDA), Meta Platforms (META), Broadcom (AVGO), CrowdStrike (CRWD), Adobe (ADBE), Advanced Micro Devices (AMD) and Salesforce (CRM).

Company Calendar

• Today: 7/16/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Pharmaceutical preparations
• Sub-Industry: Pharmaceutical Products
• Current Symbol: NASDAQ:CLVR
• CIK: 1819615
• Web: www.cleverleaves.com
• Phone: 561-634-7430
• Fax: N/A
• Employees: 560
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $17.42 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $14.02 per share
• Price / Book: 0.00

Miscellaneous

• Outstanding Shares: 1,755,000
• Free Float: 1,611,000
• Market Cap: $351.00
• Optionable: No Data
• Beta: 3,440.04